Evidence map›Paper›PMID 35144952›Full record

ArticleBMJ open2022

Using provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol.

Jane Tuckerman, Kelly Harper, Thomas R Sullivan, Jennifer Fereday, Jennifer Couper, Nicholas Smith, Andrew Tai, Andrew Kelly, Richard Couper, Mark Friswell and 4 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Jane TuckermanAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia jane.tuckerman@mcri.edu.au.ORCID 0000-0001-6938-1751
Kelly HarperWomen's and Children's Health Network, North Adelaide, South Australia, Australia.
Thomas R SullivanSAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.ORCID 0000-0002-6930-5406
Jennifer FeredayWomen's and Children's Health Network, North Adelaide, South Australia, Australia.
Jennifer CouperAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Nicholas SmithAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Andrew TaiWomen's and Children's Health Network, North Adelaide, South Australia, Australia.
Andrew KellyAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Richard CouperWomen's and Children's Health Network, North Adelaide, South Australia, Australia.
Mark FriswellWomen's and Children's Health Network, North Adelaide, South Australia, Australia.
Louise FloodCommunicable Disease Control Branch, South Australian Department of Health and Wellbeing, Adelaide, South Australia, Australia.
Margaret DanchinVaccine Uptake Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Christopher C BlythWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University Western Australia, Perth, Western Australia, Australia.
Helen MarshallAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.ORCID 0000-0003-2521-5166
Women's and Children's Health Network · AURobinson Memorial Hospital · USRoyal Children's Hospital · AUSouth Australian Health and Medical Research Institute · AUThe Kids Research Institute Australia · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInfluenza immunisation is a highly cost-effective public health intervention. Despite a comprehensive National Immunisation Program, influenza vaccination in children and adolescents with special risk medical conditions (SRMCs) is suboptimal. Flutext-4U is an innovative, multi-component strategy targeting paediatric hospitals, general practice and parents of children and adolescents with SRMC. The Flutext-4U study aims to assess the impact of Flutext-4U to increase influenza immunisation in children and adolescents with SRMC. METHODS AND ANALYSIS: This is a randomised controlled trial involving parents of children and adolescents (aged >6 months to <18 years) with SRMC receiving tertiary care at the Women's and Children's Hospital (WCH), Adelaide, South Australia, who are eligible for funded influenza immunisation with a hospital appointment between the start of the seasonal influenza vaccination season and 31 July 2021, their treating general practitioners (GPs), and WCH paediatric specialists.Parents (of children/adolescents with SRMC) are randomised (1:1 ratio) to standard care plus ETHICS AND DISSEMINATION: The protocol and all study materials have been reviewed and approved by the Women's and Children's Health Network Human Research Ethics Committee (HREC/20/WCHN/5). Results will be disseminated via peer-reviewed publication and at scientific meetings, professional and public forums. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry (ACTRN12621000463875).

Indexed as

Influenza, HumanAdolescentAustraliaChildChild HealthFemaleHumansParentsRandomized Controlled Trials as TopicVaccinationWomen's Healthpaediatric infectious disease & immunisationpreventive medicineprotocols & guidelinespublic health

Identifiers

PMID35144952
PMCPMC8845172
OpenAlexW4211058327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.